Terns Pharmaceuticals (TERN) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.35
-0.32
-0.3
-0.28

Details

Expected EPS
-0.320457
Actual EPS
-0.28
Surprise EPS
0.04
Surprise Percent
+12.62%

Description

Terns Pharmaceuticals (TERN) has reported earnings of -0.28 per share for Q4 2024.

0 Comments

Share your thoughts